Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma

Clinical trial NCT00038168 · COMPLETED

Trial details

NCT number: NCT00038168
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2000-06-01
Primary completion: 2003-01-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.